PODD · 10-Q · 2026Q3 · Full report
Research and Development Expense
INSULET CORP · 2026-11-04 · Importance 34 · Surprise 30 · In source text
Third-quarter research and development expense increased 18.7% to $91.6 million, while nine-month R&D expense rose 28.2% to $269.4 million. Selling, general and administrative expense increased 11.3% to $350.7 million for the quarter and 21.5% to $1,012.8 million for nine months. Total operating expenses rose 12.7% to $442.3 million in the quarter and 22.1% to $1,282.2 million for nine months. Stock-based compensation contributed to expense growth, reaching $20.5 million for the quarter and $61.5 million for nine months, including $50.5 million in nine-month SG&A stock compensation.
Key facts
- Research and development expense was $269.4 million for the nine months ended September 30, 2026, up $59.2 million or 28.2% from $210.2 million in 2025. source
- Research and development expense was $91.6 million for the three months ended September 30, 2026, up $14.4 million or 18.7% from $77.2 million in 2025. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | realized | -7.0% | Research and development expense was $269.4 million for the nine months ended September 30, 2026, up $59.2 million or 28.2% from $210.2… |
| operating_income | negative | realized | -1.7% | Research and development expense was $91.6 million for the three months ended September 30, 2026, up $14.4 million or 18.7% from $77.2… |